AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24735128
Drug: 720 μg
RxNorm normalized name: POLICRESULEN 720 mg in 1 g ORAL LIQUID [ALBOTHYL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 720 μg budesonide
Trial: 24735128
Drug: 1,440 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,440 μg budesonide
Trial: 24735128
Drug: four repetitive
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: four repetitive 720-μg budesonide doses
Trial: 20819220
Drug: Carbon ion
RxNorm normalized name: CARBON ION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbon ion boost applied to the macroscopic tumor up to a total dose of 18 Gy E in 6 fractions at a single dose of 3 Gy E.
Trial: 20819220
Drug: Proton boost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton boost applied up to a total dose of 10 Gy E in 5 single fractions of 2 Gy E.
Trial: 9032748
Drug: Low-dose estrogens
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose estrogens (0.625 mg of conjugated estrogens)
Trial: 3719163
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose ultrasound treatment
Trial: 30784667
Drug: Long-term dual
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term dual antiplatelet therapy (DAPT)
Trial: 16169093
Drug: Intranasal mometasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal mometasone furoate monohydrate 100 mcg/day
Trial: 15202297
Drug: ACE inhibitors,
RxNorm normalized name: ACE INHIBITORS, PLAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors, beta-blockers, and aldosterone antagonists (combined therapy)
Trial: 15202297
Drug: ACE inhibitors,
RxNorm normalized name: ACE INHIBITORS, PLAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors, beta-blockers, and aldosterone antagonists (individual drugs)
Trial: 9241006
Drug: Gepirone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gepirone (10 to 45 mg daily)
Trial: 9241006
Drug: Diazepam (19.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (19.5 +/- 12.5 mg/day)
Trial: 8309606
Drug: e.v. immunoglobulins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: e.v. immunoglobulins associated with routine antibiotic prophylaxis
Trial: 2894903
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: tubocurarine (DTC) 3 mg + succinylcholine 1.5 mg.kg‐1
Trial: 2894903
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: atracurium 0.05 mg.kg‐1 + 0.35 mg.kg‐1
Trial: 2894903
Drug: Group I:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group I: vecuronium 0.1 mg.kg‐1 as a single bolus
Trial: 3299182
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 supplementation (150 mg daily)
Trial: 30223083
Drug: liraglutide 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liraglutide 1.8 mg/day
Trial: 24283110
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg (n=98)
Trial: 21275437
Drug: Clopidogrel therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel therapy (600 mg loading dose and 75 mg/day maintenance dose) plus aspirin (300 mg/day)
Trial: 17952589
Drug: Raloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (60 mg PO daily)
Trial: 17952589
Drug: Exemestane (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane (25 mg PO daily)
Trial: 17952589
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Raloxifene 60 mg PO daily + Exemestane 25 mg PO daily)
Trial: 1289019
Drug: Bedtime insulin
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime insulin (BTI)
Trial: 1289019
Drug: Morning insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning insulin (MI)
Trial: 3881323
Drug: d-penicillamine 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-penicillamine 1200 mg daily
Trial: 31208475
Drug: Sour cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sour cream
Trial: 19555253
Drug: Fenofibrate 145
RxNorm normalized name: fenofibrate 145 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 145 mg/day
Trial: 2586204
Drug: Xipamide 20
RxNorm normalized name: xipamide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xipamide 20 mg once a day for 16 weeks
Trial: 1100213
Drug: Alpha methyldopahydrazine
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha methyldopahydrazine in combination with L-dopa
Trial: 1100213
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with L-dopa
Trial: 18648199
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 mg/day for 3 months
Trial: 18758373
Drug: Immediate-release omeprazole
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate-release omeprazole 40 mg
Trial: 20823079
Drug: Scopolamine bromide
RxNorm normalized name: Methscopolamine Bromide
DrugBank: Methscopolamine bromide (DB00462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine bromide (0.4 mg i.m.)
Trial: 17388713
Drug: Escitalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (10 mg/day increased to 20 mg/day after week 4)
Trial: 17388713
Drug: Placebo (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (after tapering from escitalopram)
Trial: 14696230
Drug: OptiMARK (gadoversetamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OptiMARK (gadoversetamide injection) administered via power injector
Trial: 11177120
Drug: Organized depression
RxNorm normalized name: Organic germanium
DrugBank: Propagermanium (DB17608)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organized depression management program including patient education, antidepressant pharmacotherapy, systematic telephone monitoring, and psychiatric consultation.
Trial: 11177120
Drug: Total health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Family Wellness Total Health]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total health services costs (including health services and time-in-treatment costs).
Trial: 11177120
Drug: Health services
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health services plus time-in-treatment costs.
Trial: 11177120
Drug: Total health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Family Wellness Total Health]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total health services and time-in-treatment costs.
Trial: 3168573
Drug: Isoetharine, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoetharine, 1 percent solution
Trial: 29197931
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (lower-limb compression therapy)
Trial: 27469583
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (1500 mg twice daily for 24 months)
Trial: 27469583
Drug: Cyclophosphamide (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide (2.0 mg/kg per day for 12 months followed by placebo for 12 months)
Trial: 20496538
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of medroxyprogesterone 500 mg/d, megestrol acetate 320 mg/d, oral supplementation with eicosapentaenoic acid (EPA), L‐carnitine 4 g/d, thalidomide 200 mg/d
Trial: 20496538
Drug: Medroxyprogesterone 500
RxNorm normalized name: medroxyprogesterone 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone 500 mg/d or megestrol acetate 320 mg/d
Trial: 8862721
Drug: Methylprednisolone 40
RxNorm normalized name: methylprednisolone 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 40 mg
Trial: 2885298
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of propranolol
Trial: 1696669
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of brefanolol
Trial: 1696669
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of brefanolol
Trial: 17419685
Drug: CEE (conjugated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE (conjugated equine oestrogen) 0.6 mg/day
Trial: 17419685
Drug: MPA (medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA (medroxyprogesterone acetate) 10 mg/day
Trial: 17419685
Drug: CEE (conjugated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE (conjugated equine oestrogen) 0.6 mg/day and MPA (medroxyprogesterone acetate) 10 mg/day
Trial: 15308069
Drug: 0.25 U.kg(‐1).d(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 U.kg(‐1).d(‐1) of rhGH treatment on 7‐10 PBD, n=16
Trial: 11217907
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone (1000 microg day(‐1))
Trial: 1434911
Drug: Ondansetron, 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron, 16 mg three times daily for 4 weeks
Trial: 2997829
Drug: Carbamazepine (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (average dosage 860 mg/day, average duration 29 days)
Trial: 26687471
Drug: L-PRF- group
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-PRF- group (n = 18)
Trial: 20554983
Drug: Protease‐inhibitor group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease‐inhibitor group
Trial: 16553019
Drug: Tiagabine 4
RxNorm normalized name: tiaGABine 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiagabine 4 mg
Trial: 16553019
Drug: Tiagabine 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiagabine 8 mg
Trial: 23526959
Drug: Albendazole treatment
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole treatment
Trial: 10664331
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation with oral antibiotics (kanamycin and metronidazole three times on the day before surgery)
Trial: 10664331
Drug: Mechanical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical preparation alone (group 1)
Trial: 17373639
Drug: Three daily
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Three daily injections of lispro plus NPH
Trial: 15800765
Drug: (18)F FDG
RxNorm normalized name: 18-F FDG
DrugBank: Fludeoxyglucose (18F) (DB09502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: (18)F FDG PET after neoadjuvant treatment
Trial: 2775617
Drug: L-648,051 12.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-648,051 12.0 mg
Trial: 778880
Drug: L-dopa with
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-dopa with carbidopa
Trial: 778880
Drug: Anticholinergic drugs
RxNorm normalized name: Anticholinergics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticholinergic drugs and/or amantadine
Trial: 10333382
Drug: Clonidine with
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine with antagonist
Trial: 2007319
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg caffeine, t.i.d., administered orally during one of the 8-day periods
Trial: 17692448
Drug: Amisulpride (458.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (458.3 mg/day)
Trial: 7625194
Drug: Moclobemide (378
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (378 mg +/‐ 76 mg/day)
Trial: 7625194
Drug: Fluoxetine (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (36 mg +/‐ 8 mg/day)
Trial: 26939318
Drug: Fire-needle treatment
RxNorm normalized name: Fire Out
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fire-needle treatment (once every two days for 30 days, 15 times total)
Trial: 19747247
Drug: Methylaminolevulinate (MAL)
RxNorm normalized name: maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylaminolevulinate (MAL) 160 mg/g cream
Trial: 16675905
Drug: Temocapril (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temocapril (1 mg daily)
Trial: 21923715
Drug: Mesalazine tablets
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesalazine tablets (3 g/day)
Trial: 15606398
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (micropellets and tablets)
Trial: 11748520
Drug: Nitroglycerin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (2 microg/kg/min infusion)
Trial: 11748520
Drug: Milrinone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milrinone (50 microg/kg loading dose)
Trial: 8491393
Drug: Loperamide‐N‐oxide (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide‐N‐oxide (3 mg orally twice daily)
Trial: 3046883
Drug: Cicletanine 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 12.5 mg daily
Trial: 3046883
Drug: Cicletanine 25
RxNorm normalized name: cicletanine
DrugBank: Cicletanine (DB12766)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 25 mg daily
Trial: 3046883
Drug: Cicletanine 50
RxNorm normalized name: cicletanine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 50 mg daily
Trial: 3046883
Drug: Cicletanine 100
RxNorm normalized name: cicletanine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 100 mg daily
Trial: 3046883
Drug: Cicletanine 200
RxNorm normalized name: cicletanine
DrugBank: Cicletanine (DB12766)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 200 mg daily
Trial: 3046883
Drug: Cicletanine 50
RxNorm normalized name: cicletanine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 50 mg daily (12 weeks)
Trial: 18450322
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus conventional-dose epirubicin (GE)
Trial: 11833826
Drug: Lovastatin ER
RxNorm normalized name: lovastatin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin ER 40 mg
Trial: 2672652
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg isosorbide dinitrate s.r. (slow release)
Trial: 25205361
Drug: Methylphenidate (MPD)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPD) at a dosage of 0.5 to 0.8 mg/kg/d
Trial: 20837928
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/d for 3 days before surgery
Trial: 22192670
Drug: Atorvastatin (ex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (ex vivo)
Trial: 11599659
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 40,000 IU s.c. once weekly (q.w.)
Trial: 10612483
Drug: Cetrorelix (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetrorelix (10 mg daily subcutaneous injections for five days and 60 mg depot)
Trial: 10612483
Drug: Cetrorelix (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetrorelix (10 mg daily intramuscular injections for five days and placebo depot)
Trial: 10612483
Drug: Placebo (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (daily and depot injections)
Trial: 7756472
Drug: Dapsone/pyrimethamine (200/75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone/pyrimethamine (200/75 mg once weekly)
Trial: 7742423
Drug: Aerosolized pentamidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized pentamidine (300 mg once every 4 weeks)
Trial: 31634023
Drug: Wixela Inhub
RxNorm normalized name: Wixela Inhub
DrugBank: Salmeterol (DB00938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Wixela Inhub (FP/salmeterol 100/50 μg)
Trial: 31634023
Drug: Advair Diskus
RxNorm normalized name: Advair Diskus
DrugBank: Salmeterol (DB00938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Advair Diskus (FP/salmeterol 100/50 μg)
Trial: 28267249
Drug: ASA 325
RxNorm normalized name: ASA 325 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 325 mg once-daily (pooled data)
Trial: 20880870
Drug: Cylinder oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cylinder oxygen provided at 6 l/min intranasally during activities provoking breathlessness
Trial: 16796502
Drug: Videoconference telepsychiatry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Videoconference telepsychiatry (VCTP) treatment
Trial: 16796502
Drug: Face-to-face conventional
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face-to-face conventional (F2FC) treatment
Trial: 16796502
Drug: Both VCTP
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both VCTP and F2FC treatments
Trial: 12752071
Drug: Antifibrinolytic agents
RxNorm normalized name: ANTIFIBRINOLYTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antifibrinolytic agents (tranexamic acid)
Trial: 12752071
Drug: Nonsteroidal anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti-inflammatory agents (mefenamic acid)
Trial: 9209517
Drug: Preoperative intraluminal
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative intraluminal brachytherapy (IBT) - moderate-dose group (16-40 Gy; n = 96)
Trial: 9209517
Drug: Preoperative intraluminal
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative intraluminal brachytherapy (IBT) - high-dose group (40-80 Gy; n = 19)
Trial: 3312501
Drug: Dilevalol 200-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol 200-800 mg/day
Trial: 24618385
Drug: ATG-F 9
RxNorm normalized name: F
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATG-F 9 mg/kg
Trial: 22409587
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (DES) for bifurcation lesions
Trial: 321727
Drug: Droperidol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (10 mg)
Trial: 6703348
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 2 mg
Trial: 8143451
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg
Trial: 15672012
Drug: Mifepristone 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 400 mg
Trial: 2782650
Drug: Slow injection
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow injection (250 sec) of 10 mg hypobaric tetracaine with epinephrine
Trial: 2782650
Drug: Fast injection
RxNorm normalized name: Fast Freeze
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fast injection (10 sec) of 10 mg hypobaric tetracaine with epinephrine
Trial: 2569394
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of somatostatin in 2 ml saline (Group I)
Trial: 2569394
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of somatostatin in 10 ml saline (Group II)
Trial: 776314
Drug: Thioridazine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thioridazine (25 mg)
Trial: 14610048
Drug: Goserelin (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin (3.6 mg every 28 days for 2 years)
Trial: 9797818
Drug: Granisetron via
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron via drip infusion with 100 ml of normal saline 30 minutes prior to CDDP administration (Group A)
Trial: 9797818
Drug: Direct injection
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct injection of granisetron into the CDDP containing bottle (Group B)
Trial: 338009
Drug: Betamethasone valerate
RxNorm normalized name: Betamethasone Valerate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone valerate inhalation (800 microgram daily)
Trial: 28249970
Drug: Ibandronate (local
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate (local bisphosphonate treatment)
Trial: 23952889
Drug: 1,200 mg
RxNorm normalized name: lecithin 1,200 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,200 mg of NAC
Trial: 23952889
Drug: 2,400 mg
RxNorm normalized name: pancreatin/lipase/protease/amy 2,400 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2,400 mg of NAC
Trial: 21412846
Drug: Clozapine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine (300 mg/day)
Trial: 21412846
Drug: Haloperidol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (15 mg/day)